Comparing the Efficacy of Intravitreal Anti-VEGF Agents in the Treatment of Wet AMD

Diana V. Do, MD

Show Description +

Diana V. Do, MD, provides an update on a study she and her colleagues conducted comparing the efficacy of different intravitreal anti-VEGF agents in the treatment of wet AMD.

Posted: 11/05/2020

Keywords:

Anti-VEGF

•

Intravitreal Therapy

•

retina-meeting-recap

•

Wet AMD

•

Retina Subspecialty Day

Up Next

Name: Comparing the Efficacy of Intravitreal Anti-VEGF Agents in the Treatment of Wet AMD
Uploaded: 2020-11-05T15:58:00+00:00
Description: Diana V. Do, MD, provides an update on a study she and her colleagues conducted comparing the efficacy of different intravitreal anti-VEGF agents in the treatment of wet AMD.

$Managing Postoperative Refractive Errors$

Managing Postoperative Refractive Errors

Elizabeth Yeu, MD

IOL Power Calculations After Excimer Laser Surgery

Seth M. Pantanelli, MD

Entrustable Physician Activities

Thomas A. Oetting, MD

Ray-Tracing Optimization for Myopic LASIK

A. John Kanellopoulos, MD

A Deep-Learning Neural Network for Diagnosing Corneal Diseases

Mohamed Abou Shousha, MD, FRCS, PhD

Predicting Graft Survival After PKP

Eric J. Shiuey, MS

The Future of Limbal Stem Cell Transplantation

Ashiyana Nariani, MD, MPH,

Virtual Reality-Based Visual Field Testing

Yvonne Ou, MD

Surgical Considerations in Neovascular Glaucoma: The Retina Perspective

Rishi P. Singh, MD

Evaluating Glaucomatous Progression in the Setting of Retinal Disease

Yao Liu, MD, MS

Stimulating the Optic Nerve With Alternating Microcurrents

Bernhard A. Sabel, PhD

Diagnostic and Therapeutic Vitrectomy in Uveitis

Lisa J. Faia, MD

Receptor Interplay and Retinal Disease

Peter Kaiser, MD

The Status of Cell Therapy for Atrophic AMD

Allen C. Ho, MD

A Targeted Therapy for the Treatment of Choroidal Melanoma

Carol Shields, MD

Deep Learning: OCT and Disease Prediction

Tien Y. Wong, MD, MBBS, MPH, FRCS(Ed), Phd

Presbyopia-Correcting IOLs vs. Monofocal IOLs

Julie Schallhorn, MD

Genetic Targeting & Glaucoma

Milica Margeta, MD

Lessons Learned from the COVID-19 Pandemic

Ranya Habash, MD

Light Adjustable Lens and Radial Keratotomy

James D. Lehmann, MD

Does This New IOL Deliver?

Devesh K. Varma, MD

Managing Cataract Surgery for Patients With High Hyperopia

Douglas Koch, MD

$How to Enhance Refractive Surgery of Hyperopia$

How to Enhance Refractive Surgery of Hyperopia

Jorge Alio MD

Maintaining Resilience and Avoiding Burnout

Julia Haller, MD

Evaluation of Avacincaptad Pegol for the Treatment of GA Associated With AMD

Donald J. D'Amico, MD

Management of High-Risk NPDR Today and Tomorrow

Charles C. Wykoff, MD, PhD

OCT-A Metrics Predict Diabetic Retinopathy Disease Progression

Nadia K. Waheed, MPH, MD

A Research Analysis of Brolucizumab in the Real World

Michael S. Ip, MD

Back to All Videos

Comparing the Efficacy of Intravitreal Anti-VEGF Agents in the Treatment of Wet AMD

Diana V. Do, MD

Diana V. Do, MD, provides an update on a study she and her colleagues conducted comparing the efficacy of different intravitreal anti-VEGF agents in the treatment of wet AMD.

Posted: 11/05/2020

Keywords:

Anti-VEGF

•

Intravitreal Therapy

•

retina-meeting-recap

•

Wet AMD

•

Retina Subspecialty Day

Please log in to leave a comment.

Meeting Coverage:

American Academy of Ophthalmology

Comparing the Efficacy of Intravitreal Anti-VEGF Agents in the Treatment of Wet AMD

Up Next

Comparing the Efficacy of Intravitreal Anti-VEGF Agents in the Treatment of Wet AMD

More From AAO: 2020 Coverage